◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

凯莱英

凯莱英
Loading...
Key Metrics
Market Cap
34.3B ($5.0B)
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
5.8B
Net Income
936.0M
Gross Margin
N/A
Op. Margin
18.6%
Net Margin
16.1%
ROE
5.6%
ROA
4.9%
D/E
0.14
Dividend Yield
N/A
EPS
2.69
Current Ratio
6.47
Price History
Company Info
IndustryC27医药制造业
Market SegmentSME
CurrencyCNY
Fiscal Year2024
Business Overview

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystalliza...

Peers
工商银行
601398
2.7T
P/E: 7.6
建设银行
601939
2.5T
P/E: 7.2
农业银行
601288
2.4T
P/E: 8.7
中国海油
600938
2.0T
P/E: 16.2
宁德时代
300750
1.9T
P/E: 25.6
贵州茅台
600519
1.8T
P/E: 20.1
中国银行
601988
1.8T
P/E: 7.3
中国人寿
601628
1.2T
P/E: 6.9
Financial Statements
Loading financials...
Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 凯莱英

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, and continuous flow; and chemical process R&D, analytical services, regulatory, pre-clinical R&D support, PPQ readiness, and back integration services. It also engages in technology services comprising flow chemistry, biocatalysis, fermentation, chiral synthesis, hazardous reactions, low temperature, highly potent, non-precious metal catalysis (NPMC), high-pressure chemistry, electrochemistry, and photochemistry. In addition, the company offers drug products, such as pharma solutions, preformulation, solid oral dosage, and injectables; and biotech solutions, drug substance and development, and consultation services. The company was founded in 1998 and is headquartered in Tianjin, China.


Ticker002821
ExchangeSZSE
Sector证监会行业分类
IndustryC27医药制造业
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...